Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015, and Company''s code of conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges that its trading window will be closed starting January 1, 2026, in line with SEBI Insider Trading Regulations and the company's internal code of conduct. The window will reopen only 48 hours after the company publicly announces its unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. The date of the board meeting to approve these quarterly results has not yet been announced and will be communicated later. All promoters, designated persons, and connected persons are prohibited from trading in the company's shares during this closed period.
This is a routine compliance announcement and does not signal any corporate action. The window closure simply prevents insiders from trading before the upcoming Q3 FY26 results, meaning retail investors should watch for the results announcement in January 2026, which could be a potential stock-moving event.